Bio-Techne Corporation
Revenue Breakdown
| Fiscal Year | Biotechnology | Clinical Controls | Protein Platforms | Protein Sciences | Diagnostics and Genomics | Diagnostics and Spatial Biology | Other | Eliminations |
|---|---|---|---|---|---|---|---|---|
| FY2016 | $317.3M | $104.5M | $77.3M | $0 | $0 | $0 | $0 | $-125.0K |
| FY2017 | $0 | $0 | $0 | $419.4M | $143.7M | $0 | $0 | $-104.0K |
| FY2018 | $0 | $0 | $0 | $482.4M | $161.2M | $0 | $0 | $-536.0K |
| FY2019 | $0 | $0 | $0 | $543.2M | $171.7M | $0 | $0 | $-827.0K |
| FY2020 | $0 | $0 | $0 | $555.4M | $184.5M | $0 | $0 | $-1.2M |
| FY2021 | $0 | $0 | $0 | $704.6M | $227.7M | $0 | $0 | $-1.3M |
| FY2022 | $0 | $0 | $0 | $832.3M | $274.8M | $0 | $0 | $-1.6M |
| FY2023 | $0 | $0 | $0 | $845.7M | $0 | $292.6M | $0 | $-1.6M |
| FY2024 | $0 | $0 | $0 | $830.9M | $0 | $326.4M | $4.2M | $-2.4M |
| FY2025 | $0 | $0 | $0 | $870.2M | $0 | $346.3M | $4.2M | $-1.0M |